Skip to content
value.today

Athersys, Inc / New

Formerly BTHC VI, Inc

Total raised
$13 M
2 rounds on record
Latest round
$4 M
Apr 2023
First round on record
Mar 2012
Today
Private
No later event on record

Funding rounds

2 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Athersys, Inc / New
MonthRaisedRaiseSizeInvestorsSoldFiling
Apr 2023$4 MNo. 2$2 to $10 million

Athersys, Inc / New: Raise no. 2, Apr 2023

Investors in this round

4 investors had bought by the notice of May 1, 2023: 4 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$4 M of $4 M offered
Smallest investment taken
no minimum stated
What was sold
options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$239,516
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions and payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Daniel Camardo · Executive Officer, Director
  • Kasey Rosado · Executive Officer
  • Maia Hansen · Executive Officer
  • Ismail Kola · Director
  • Jack Wyszomierski · Director
  • Jane Wasman · Director
  • Joseph Nolan · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • A.G.P/ALLIANCE GLOBAL PARTNERS (CRD 8361) · New York, New YorkSold in CA, IL, NY

Remarks in the notice

  • On fees: “ATHERSYS, INC WILL PAY A.G.P./ALLIANCE GLOBAL PARTNERS A CASH FEE EQUAL TO 6.5% OF THE AGGREGATE PROCEEDS FROM THE SALE OF COMMON STOCK AND THE WARRANTS, PLUS UP TO AN ADDITIONAL $65,000 IN OTHER ACCOUNTABLE AND NON-ACCOUNTABLE EXPENSES.”
  • On the amounts: “WARRANTS TO PURCHASE UP TO 3,685,000 SHARES OF COMMON STOCK, AT AN EXERCISE PRICE EQUAL TO $0.96 PER SHARE, WERE ISSUED FOR NO ADDITIONAL CONSIDERATION CONCURRENTLY WITH A REGISTERED DIRECT OFFERING OF 3,685,000 SHARES OF COMMON STOCK”
  • On the use of proceeds: “THE COMPANY INTENTS TO USE THE NET PROCEEDS FROM THIS OFFERING FOR WORKING CAPITAL AND GENERAL CORPORATE PURPOSES, WHICH MAY INCLUDE PAYING SALARIES TO SOME RELATED PERSONS LISTED HEREIN.”

Signed by Daniel Camardo, Ceo. Source: SEC Form D, newest notice filed May 1, 2023. Read the notice at the SEC.

optionsSEC
Mar 2012$9 MNo. 1$2 to $10 million

Athersys, Inc / New: Raise no. 1, Mar 2012

Investors in this round

20 investors had bought by the notice of Mar 22, 2012: 20 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$9 M of $18 M offered; $9 M still to sell
Smallest investment taken
$20,000
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
$5 million to $25 million
Sales commissions
$705,000
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Gil Van Bokkelen · Executive Officer, Director · Chairman of the Board of Directors and Chief Executive Officer
  • John J. Harrington · Executive Officer, Director · Executive Vice President, Chief Scientific Officer and Director
  • Laura K. Campbell · Executive Officer · Vice President, Finance
  • William L. Lehmann · Executive Officer · President, Chief Operating Officer and Secretary
  • George M. Milne · Director
  • Ismail E. Kola · Director
  • Jack L. Wyszomlerski · Director
  • Lee E. Babiss · Director
  • Lorin J. Randall · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Piper Jaffray & Co. (CRD 665) · New York, New YorkSold in IL, NJ, NY, OH, PA
  • William Blair & Company (CRD 1252) · Chicago, IllinoisSold in IL, NJ, NY, OH, PA
  • First Analysis Securities Corporation (CRD 10446) · Chicago, IllinoisSold in IL, NJ, NY, OH, PA
  • WBB Securities, LLC (CRD 118440) · San Diego, CaliforniaSold in no state named

Remarks in the notice

  • On fees: “Piper Jaffray & Co. acted as sole lead placement agent. William Blair & Company and First Analysis Securities Corporation acted as co-placement agents. WBB Securities, LLC acted as financial advisor. The total amount paid to these entities was $705000.”
  • On the amounts: “The total offering amount includes amounts receivable by the issuer upon the exercise of warrants to purchase Athersys, Inc.'s common stock, assuming no cashless exercise. Such warrants have not yet been exercised.”

Signed by Laura K. Campbell, Vice President, Finance. Source: SEC Form D, newest notice filed Mar 22, 2012. Read the notice at the SEC.

equity, optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Athersys, Inc / New chose not to state its revenue in its newest notice of a funding round (May 2023).

    SEC Form D · May 2023

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · May 2023

That is all the official record says: Athersys, Inc / New has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: its website does not describe any in structured form (a page that declares itself a product or service), and Wikidata lists none.

Investors#

No investor of Athersys, Inc / New is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 2 rounds above had up to 20 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Athersys, Inc / New
NameRoleNamed in
Daniel CamardoExecutive officerMay 2023
Kasey RosadoExecutive officerMay 2023
Maia HansenExecutive officerMay 2023
Gil Van BokkelenChairman of the Board of Directors and Chief Executive OfficerMar 2012
John J. HarringtonExecutive Vice President, Chief Scientific Officer and DirectorMar 2012
Laura K. CampbellVice President, FinanceMar 2012
William L. LehmannPresident, Chief Operating Officer and SecretaryMar 2012
Daniel CamardoDirectorMay 2023
Ismail KolaDirectorMay 2023
Jack WyszomierskiDirectorMay 2023
Jane WasmanDirectorMay 2023
Joseph NolanDirectorMay 2023
George M. MilneDirectorMar 2012
Gil Van BokkelenChairman of the Board of Directors and Chief Executive OfficerMar 2012
Ismail E. KolaDirectorMar 2012
Jack L. WyszomlerskiDirectorMar 2012
John J. HarringtonExecutive Vice President, Chief Scientific Officer and DirectorMar 2012
Lee E. BabissDirectorMar 2012
Lorin J. RandallDirectorMar 2012

About

Biotechnology company in Cleveland, United States.